Brainstorm Cell Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Brainstorm Cell Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Brainstorm Cell Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Brainstorm Cell Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $21k | 77k | 0.27 |
| 2023-09-30 | $42k | 210k | 0.20 |
| 2023-06-30 | $404k | 196k | 2.06 |
| 2023-03-31 | $664k | 201k | 3.30 |
| 2022-12-31 | $292k | 178k | 1.64 |
| 2022-06-30 | $0 | 139k | 0.00 |
| 2022-03-31 | $398k | 119k | 3.34 |
| 2021-12-31 | $811k | 203k | 4.00 |
| 2021-09-30 | $690k | 220k | 3.13 |
| 2021-06-30 | $1.1M | 301k | 3.80 |
| 2021-03-31 | $1.3M | 334k | 3.83 |
| 2020-12-31 | $1.4M | 300k | 4.53 |
| 2020-09-30 | $5.5M | 325k | 16.92 |
| 2020-06-30 | $2.5M | 225k | 11.21 |
| 2020-03-31 | $639k | 138k | 4.64 |
| 2019-12-31 | $220k | 52k | 4.25 |
| 2019-06-30 | $157k | 40k | 3.93 |
| 2019-03-31 | $154k | 36k | 4.31 |
| 2018-12-31 | $39k | 11k | 3.59 |
| 2018-09-30 | $104k | 27k | 3.80 |
| 2018-06-30 | $96k | 25k | 3.92 |
| 2017-12-31 | $59k | 15k | 3.92 |
| 2017-09-30 | $106k | 26k | 4.12 |
| 2017-06-30 | $134k | 32k | 4.17 |
| 2017-03-31 | $74k | 17k | 4.26 |
| 2016-03-31 | $32k | 12k | 2.68 |